6
Oct
2026
Shenyang BrightGrandeur Pharma
Exhibitor at CPHI Milan 2026 stand 20H69, Finished Dosage & Formulation
About Us
Categories
-
Country/Region:China
-
On CPHI since:2025
-
Employees:50 - 99
Company types
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 20H69, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Chorionic Gonadotrophin for Injection
Chorionic Gonadotrophin for Injection is a gonadotropin injectable preparation whose main active ingredient is human chorionic gonadotropin (HCG). By supplementing the level of gonadotropin in the body, it regulates reproductive endocrine function. It is indicated for anovulatory infertility, luteal phase ... -
Product Omeprazole Sodium for Injection
Injection Omeprazole Sodium is a potent gastric acid inhibitor belonging to the class of proton pump inhibitors (PPIs). It works by directly targeting the "final switch" of gastric acid secretion—the proton pump—to rapidly and effectively suppress acid production.
This product is a prescription-... -
Product Products Catalog
We specialize in the production of lyophilized powder injections, including hormone-based formulations. With an annual production capacity exceeding 20 million vials, we also offer reliable Contract Manufacturing Organization (CMO) services. Please refer to our product catalog for detailed specifications. -
Product Urokinase for Injection
Urokinase for Injection is a thrombolytic agent that acts directly on the fibrinolytic system.
Core Indications:Acute Cardiovascular Embolism: Acute myocardial infarction, acute massive pulmonary embolism.
Acute Cerebrovascular Embolism: Acute phase of cerebral embolism.
Perip...



